Foundation Medicine, Flatiron Health roll out clinico-genomic oncology database
Cambridge, Mass.-based genomic analysis company Foundation Medicine and New York-based software company Flatiron Health have launched a HIPAA-compliant information database to assist cancer researchers.
The clinico-genomic database, which contains information related to almost 20,000 patients, integrates data from patients whose tumors were sequenced with Foundation Medicine's genomic profiling assays. This information is continuously updated with clinical and outcomes data from EHRs, provided by Flatiron Health. The database allows researchers to see a longitudinal view of a patient's clinical, diagnostic and therapeutic outcomes.
The data includes genomic information, clinical characteristics, treatments received, patient-level outcomes, tumor response and mortality. The ultimate goal is to provide researchers with information to develop precise therapeutics and immunotherapies for cancer patients.
More articles on health IT:
Mount Sinai Health System launches app-prescription platform RxUniverse
Study: Does electronic prescribing impact medication adherence?
Avera McKennan leverages Meditech EHR for emergency department nurse navigator program
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.